In this episode of UWO Now, host Wendell Ray speaks with Jessica Habeck, DNP, from the UW-Oshkosh School of Nursing about GLP‑1 medications and their role in weight loss, diabetes treatment, and metabolic health.

The discussion explains how drugs like Ozempic, Wegovy, Mounjaro, and Zepbound mimic natural hormones that regulate appetite and blood sugar. The conversation also addresses who qualifies for these medications, the dangers of compound and counterfeit versions, and why GLP‑1 therapies must be combined with lifestyle and medical supervision.

A clear and practical conversation for anyone curious about the science and safety behind the most talked‑about weight‑loss medications today.

Learn more:

• • ‘UWO Now’ podcast: Meet Chancellor Manohar Singh
  • UWO Now podcast: Artificial intelligence in our lives
  •  ‘UWO Now’ podcast: Rob Kleman, discusses Oshkosh Chamber’s link with education
  • ‘UWO’ podcast: Talk of climate change migration heats up
  • ‘UWO Now’ podcast: Skimming Wisconsin waterways with Greg Kleinheinz
  • UWO Now podcast: AI In Our Lives 2026, featuring UWO Assistant Professor of IS Jeremiah Bohr